cisplatin,pembrolizumab,gemcitabine
merck
['pembro', 'cisplatin', 'hcrn gu14-188', 'urothelial', ' cis ', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)']
#gu23 #drjasonbrown presents data from hcrn gu14-188a neoadjuvant pembrolizumab and chemotherapy for t2-4an0m0 urothelial cancer.
- primary endpoint met in both cis eligible and ineligible cohorts - further studies going on for chemo-immunotherapy in muscle invasive urothelial 
GU Oncologist/Clinical Trials/ Experimental Therapeutics @UCD_Cancer @UCDavisHealth via @uofcincy @GoBEARCATS. Tweets= My opinions #RCC #ASCO #immunotherapy